Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Xencor (XNCR) stock in plain English

Free brief · no signupStart here
XNCRPublished Nov 19, 2026
Xencor Inc
Healthcare · Biotechnology
Develops engineered antibody therapeutics for oncology and autoimmune diseases using proprietary protein modification technology.
Assets:
XmAb platformProprietary Fc domain engineering technology powering internal and partnered drug programs
Pasadena facilityLeased corporate headquarters and research laboratories located in California
Commercial partnershipsLicensing agreements generating royalties and milestones with partners such as Novartis and Genentech
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

57
OPS ScoreOperating finances
Latest quote
-1.10%$34.01
$2.55B
n/a (loss)
$200.48M

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 19, 2026Quotes updated Nov 20, 04:10 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was XNCR. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Xencor (XNCR) do?

Xencor Inc (XNCR) is a U.S.-listed company in Healthcare (Biotechnology). What it does: Develops engineered antibody therapeutics for oncology and autoimmune diseases using proprietary protein modification technology. The company engineers antibody proteins by altering Fc domains to treat cancer and autoimmune disorders. It is worth $2.55B on the market and sold $200.48M over the last year.

Market cap
$2.55B
P/E ratio
None (reported a loss)
Annual sales
$200.48M
Sector
Healthcare
Industry
Biotechnology
Brief updated
Nov 19, 2026

XNCR’s flags, in plain English

Each flag is a number from Xencor’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.

Stupid Cash

Can pay this year's bills 6.5 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Wide Gross Margin

Gross margin of 95.1% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Low debt

Low debt, only 29% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Burning Cash

Losing money, profit margin of -58.8%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.

1 more green flag and 2 more risk notes open with the free trial. Try it free for 7 days.

Questions about XNCR

How big is Xencor?

Xencor’s market cap is $2.55B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $200.48M: what customers paid the company over the last year, before any costs.

What is XNCR’s P/E ratio?

XNCR has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.

What could go wrong with XNCR?

The company generates irregular revenue that depends heavily on partner milestone payments rather than recurring product sales. That is one risk on Xencor’s card. Its first risk flag is Burning Cash, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Xencor’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. XNCR’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card